)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Century Therapeutics
Century Therapeutics (IPSC) investor relations material
Century Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Apr, 2026
Executive summary
Annual Meeting scheduled for June 11, 2026, at 9:00 a.m. Eastern Time, to be held virtually.
Proxy materials, including the Notice, Proxy Statement, and Annual Report, are available online for review and voting.
Voting matters and shareholder proposals
Election of two Class II directors, Alessandro Riva, M.D., and Han Lee, Ph.D., M.B.A., for a three-year term expiring in 2029.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for 2026.
Proposal to amend the Certificate of Incorporation to increase authorized common stock from 300,000,000 to 450,000,000.
Proposal to approve adjournment of the meeting if there are insufficient votes to approve the Charter Amendment Proposal.
Board recommends voting FOR all nominees and all proposals.
Board of directors and corporate governance
Board nominates Alessandro Riva, M.D., and Han Lee, Ph.D., M.B.A., for re-election as Class II directors.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Century Therapeutics
- Lead iPSC-derived therapies for diabetes and autoimmune diseases advance toward clinical trials.IPSC
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Annual Meeting to vote on director elections, auditor ratification, and share authorization increase.IPSCProxy filing27 Apr 2026
- Stockholders will vote on director elections, auditor ratification, and a major charter amendment.IPSCProxy filing16 Apr 2026
- Lead cell therapy programs advanced, net loss narrowed, and cash runway extended into 2029.IPSCQ4 202512 Mar 2026
- Pivot to iPSC-derived beta islet therapy for type 1 diabetes, IND in late 2025, data in 2027.IPSCLeerink Global Healthcare Conference 202610 Mar 2026
- Raised $135M to advance iPSC cell therapies; registration enables resale of 176M shares.IPSCRegistration Filing5 Feb 2026
- iPSC cell therapies show strong safety, efficacy, and promise for autoimmune and oncology.IPSCGuggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026
- Promising clinical and preclinical progress, platform advances, and strong partnerships drive outlook.IPSCPiper Sandler 36th Annual Healthcare Conference11 Jan 2026
- Shelf registration allows flexible capital raising with strong management and indemnification.IPSCRegistration Filing5 Jan 2026
Next Century Therapeutics earnings date
Q1 202611 May, 2026
Century Therapeutics
Next Century Therapeutics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage